| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹14,902 | -0.65% | |
| 6 months | ₹30,000 | ₹29,580 | -1.40% | |
| 1 year | ₹60,000 | ₹59,614 | -0.64% | |
| 3 years | ₹1,80,000 | ₹1,78,508 | -0.83% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Bosch Ltd | Consumer Discretionary | Equity | 6.78% |
| Mphasis Ltd | Technology | Equity | 5.74% |
| Pidilite Industries Ltd | Materials | Equity | 5.49% |
| Marico Ltd | Consumer Staples | Equity | 5.34% |
| Hero Motocorp Ltd | Consumer Discretionary | Equity | 5.24% |
| The Great Eastern Shipping Company Ltd | Energy & Utilities | Equity | 5.23% |
| Page Industries Ltd | Consumer Discretionary | Equity | 4.85% |
| Akzo Nobel India Ltd | Materials | Equity | 4.63% |
| ABB India Ltd | Industrials | Equity | 4.59% |
| AU Small Finance Bank Ltd | Financial | Equity | 4.29% |
| Britannia Industries Ltd | Consumer Staples | Equity | 4.19% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 4.11% |
| Crisil Ltd | Industrials | Equity | 3.70% |
| Bayer CropScience Ltd | Materials | Equity | 3.53% |
| Can Fin Homes Ltd | Financial | Equity | 3.42% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 3.31% |
| Divi's Laboratories Ltd | Healthcare | Equity | 3.27% |
| Abbott India Ltd | Healthcare | Equity | 3.22% |
| Alkem Laboratories Ltd | Healthcare | Equity | 3.18% |
| HDFC Asset Management Company Ltd | Financial | Equity | 3.03% |
| Muthoot Finance Ltd | Financial | Equity | 2.84% |
| Pfizer Ltd | Healthcare | Equity | 2.69% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 2.50% |
| UTI Asset Management Company Ltd | Financial | Equity | 2.26% |
| Aptus Value Housing Finance India Ltd | Financial | Equity | 2.17% |
| Others CBLO | Unspecified | CBLO | 0.56% |
| Net Payables | Unspecified | Net Payables | -0.13% |
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +0.0% | -3.6% | +6.8% | +10.9% |
| Category average (Equity ELSS) | +8.1% | +1.8% | +12.7% | +17.3% |
| Rank (Equity ELSS) | -- | 39 | 38 | -- |